Lucira Health, Inc.
LHDX · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $34,390 | $26,146 | $90,474 | $61,124 |
| % Growth | 31.5% | -71.1% | 48% | – |
| Cost of Goods Sold | $133,945 | $18,154 | $50,558 | $48,499 |
| Gross Profit | -$99,555 | $7,992 | $39,916 | $12,625 |
| % Margin | -289.5% | 30.6% | 44.1% | 20.7% |
| R&D Expenses | $9,141 | $10,753 | $12,195 | $9,099 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $17,596 | $18,628 | $13,909 | $11,533 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$204 |
| Operating Expenses | $26,737 | $29,381 | $26,104 | $20,428 |
| Operating Income | -$126,292 | -$21,389 | $13,812 | -$7,803 |
| % Margin | -367.2% | -81.8% | 15.3% | -12.8% |
| Other Income/Exp. Net | -$556 | -$545 | -$475 | $209 |
| Pre-Tax Income | -$126,848 | -$21,934 | $13,337 | -$7,798 |
| Tax Expense | $14 | -$257 | $259 | -$255 |
| Net Income | -$126,862 | -$21,677 | $13,078 | -$7,543 |
| % Margin | -368.9% | -82.9% | 14.5% | -12.3% |
| EPS | -3.15 | -0.54 | 0.31 | -0.19 |
| % Growth | -483.3% | -274.2% | 263.2% | – |
| EPS Diluted | -3.15 | -0.54 | 0.31 | -0.19 |
| Weighted Avg Shares Out | 40,216 | 39,928 | 41,833 | 39,030 |
| Weighted Avg Shares Out Dil | 40,216 | 39,928 | 41,833 | 39,030 |
| Supplemental Information | – | – | – | – |
| Interest Income | $393 | $281 | $62 | $0 |
| Interest Expense | $949 | $826 | $537 | $0 |
| Depreciation & Amortization | $2,133 | $1,957 | $62 | $1,246 |
| EBITDA | -$124,159 | -$19,432 | $13,936 | -$6,557 |
| % Margin | -361% | -74.3% | 15.4% | -10.7% |